Physician profile
Aryeh Shander
NPI 1578541942
$761,611.76
in general payments reported to CMS, 2019-2025
19 companies · $2,014 in 2025
The $2,014 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169K · 2020: $82K · 2021: $157K · 2022: $87K · 2023: $72K · 2024: $193K · 2025: $2,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $89K · Consulting Fee: $81K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Travel and Lodging: $28K · Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $88,751.00 |
| Consulting Fee | $81,338.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,462.50 |
| Travel and Lodging | $27,955.03 |
| Food and Beverage | $2,034.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $236,519.53 | 2019-2025 | Kcentra |
| Pharmacosmos Therapeutics INC. | $226,678.96 | 2020-2025 | Monoferric |
| Stryker Corporation | $97,728.07 | 2021 | |
| Masimo Corporation | $73,280.11 | 2019-2020 | |
| Baxter Healthcare | $31,690.24 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27,655.29 | 2019 | |
| Grifols USA, LLC | $20,381.62 | 2020-2025 | Thrombate III |
| Daiichi Sankyo INC. | $19,470.11 | 2019-2022 | |
| Vifor (International) LTD. | $12,688.60 | 2020-2023 | |
| Amag Pharmaceuticals, INC. | $7,467.67 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $2,500.00 | 2022 | |
| Grifols Shared Services North America, INC. | $2,364.47 | 2019-2025 | |
| American Regent | $1,252.64 | 2019 | |
| Shire North American Group INC | $904.61 | 2019 | |
| Instrumentation Laboratory Company | $700.00 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Werfen USA LLC | $175.08 | 2022-2023 | |
| Medtronic Vascular, INC. | $125.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2023 | Exparel, Iovera, Zilretta |
| Trevena, INC. | $14.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aryeh Shander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.